Literature DB >> 15227407

Current status of thrombolytic therapy in acute myocardial infarction.

B Stein1, R Roberts.   

Abstract

Entities:  

Year:  1991        PMID： 15227407      PMCID： PMC326349     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  38 in total

1.  Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms.

Authors:  P R Puleo; M B Perryman
Journal:  J Am Coll Cardiol       Date:  1991-04       Impact factor: 24.094

2.  A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group.

Authors:  P L Thompson; P E Aylward; J Federman; R W Giles; P J Harris; R L Hodge; G I Nelson; A Thomson; A M Tonkin; W F Walsh
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

3.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors:  R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

4.  Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator.

Authors:  K L Neuhaus; W Feuerer; S Jeep-Tebbe; W Niederer; A Vogt; U Tebbe
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

5.  A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.

Authors:  J Hsia; W P Hamilton; N Kleiman; R Roberts; B R Chaitman; A M Ross
Journal:  N Engl J Med       Date:  1990-11-22       Impact factor: 91.245

6.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.

Authors:  J S Hochman; H Choo
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

7.  Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.

Authors:  D C Gulba; M Barthels; M Westhoff-Bleck; S Jost; W Rafflenbeul; W G Daniel; H Hecker; P R Lichtlen
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

8.  Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study.

Authors:  I E Kersschot; P Brugada; M Ramentol; M Zehender; B Waldecker; W G Stevenson; A Geibel; C De Zwaan; H J Wellens
Journal:  J Am Coll Cardiol       Date:  1986-06       Impact factor: 24.094

9.  Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

Authors:  J M Gore; M Sloan; T R Price; A M Randall; E Bovill; D Collen; S Forman; G L Knatterud; G Sopko; M L Terrin
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

10.  Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.

Authors:  M Heras; J H Chesebro; W J Penny; K R Bailey; L Badimon; V Fuster
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.